Skip to main content

Table 2 Correlation between DRAM2 expressiom and clinicopathological factors in 259 NSCLC patients

From: DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53

Clinicopathological factors Number of patient DRAM2 negative or weak expression DRAM2 over expression P
Gender  
 Male 163 59 104 0.498
 Female 96 30 66
Age  
  > 60 121 41 80 0.896
  ≤ 60 138 48 90
Histology  
 Squamous cell carcinoma 103 37 66 0.69
 Adenocarcinoma 156 52 104
Differentiation  
 Well 118 43 75 0.599
 Moderate-Poor 141 46 95
Lymph node metastasis  
 Negative 148 59 89 0.035
 Positive 111 30 81
TNM stage  
 I 114 48 66 0.025
 II + III 145 41 104
  1. *p < 0.05; **p < 0.01